[5 years' ambulatory care experience with the clonidine stimulation test]
Related Experiment Videos
A Tesarová1, D Marsálková, M Slavícková
1Klinika dĕtského a dorostového lékarství a dĕtské oddĕlení fakultní polikliniky, lékarské fakulty Univerzity Karlovy, Praha.
Insights
The clonidine stimulation test is a safe and effective method for screening growth hormone (GH) secretion in children with small stature. This five-year study found the test to be highly useful, with a high rate of positive results.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Physiology
- Diagnostic Testing
Background:
- Growth hormone (GH) deficiency is a primary cause of idiopathic short stature in children.
- Accurate assessment of GH secretion is crucial for diagnosis and treatment planning.
- Existing diagnostic methods can be invasive or complex.
Purpose of the Study:
- To evaluate the efficacy and safety of the clonidine stimulation test for assessing growth hormone secretion in children.
- To determine the diagnostic accuracy and reliability of the clonidine test over a five-year period.
Main Methods:
- A cohort of 231 children with small stature underwent oral administration of clonidine (0.1 mg/m2 body surface area).
- Blood samples were collected at baseline, 60 minutes, and 90 minutes post-administration.
- Growth hormone levels were measured to assess secretory response.
Main Results:
- The clonidine test yielded a positive growth hormone response in 75% of children (174/231).
- Negative responses were observed in 13% (30/231), and marginal responses in 12% (27/231).
- The rate of falsely negative tests was estimated to be a maximum of 10%.
Conclusions:
- The clonidine stimulation test is a valuable, simple, and safe screening tool for evaluating growth hormone secretion in pediatric patients.
- Its ease of use and high diagnostic utility make it suitable for ambulatory clinical practice.
- The test provides reliable information for the initial assessment of short stature in children.
Abstract:
The authors give an account of their five-year experience with the clonidine test of growth hormone (GH) secretion. They used the test in 231 children examined on account of small stature. They administered 0.1 mg clonidine/m2 body surface by the oral route; blood specimens were collected at time 0, 60 and 90 minutes after administration of the preparation. They recorded 174 positive GH responses (75%), 30 negative responses (13%) and 27 marginal responses (12%). Falsely negative tests were recorded in a maximum of 10%. The test is a very useful screening examination of GH secretion due to the useful information it provides, and because it is simple and safe even when used in ambulatory practice.